dQ&A

What dQ&A does

dQ&A is a privately held, San Francisco-based diabetes market research and insights company founded in 2009 by Richard Wood and Kelly Close. The company operates as a social enterprise focused exclusively on diabetes, maintaining proprietary, hand-picked patient and prescriber panels across nine countries in North America and Europe. Its core products are syndicated Data Services (longitudinal tracking studies such as T2 Insulin Insights, Diabetes Drug Trends covering GLP-1 and SGLT2 therapies, and DHx, a digital health app evaluation service), Custom Research (bespoke qualitative and quantitative studies), and an upcoming AI Insights Platform in beta as of October 2025 with formal launch planned for early 2026. The AI platform uses natural language processing to allow clients to query a 15-year proprietary data lake of millions of survey responses and generate visualizations for reports and presentations.

dQ&A monetizes through a mix of recurring syndicated subscriptions, custom research engagements, and soon, a SaaS-style AI access layer, with pricing provided on a quote basis to enterprise clients. The customer base spans pharmaceutical companies, medical device manufacturers, digital health firms, consumer goods manufacturers, and healthcare providers. Distribution is sales-led, with direct enterprise engagement supported by conference presence (ATTD, EASD), peer-reviewed publications in journals including Clinical Diabetes and Current Diabetes Reports, and an FDA advisory committee presentation in 2019. A 2023 strategic partnership with LMC Healthcare (Diadem Insights) integrates dQ&A's patient experience data with LMC's clinical database of 50,000+ patients to create combined real-world evidence assets. The company has completed 400+ client projects, answered over 10 million research questions, and collected 500,000+ completed surveys across its panel over 15 years of operation.

Name

dQ&A

Legal name

dQ&A Market Research Inc.

Website

https://d-qa.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

dQ&A is a privately held, San Francisco-based diabetes market research firm founded in 2009 that provides syndicated data services, custom research, and an AI-powered insights platform to pharmaceutical, medical device, and digital health companies across nine countries.

Ownership category

akta.pro rank

Product category

Healthcare Market Research & Insights

NAICS

Marketing Research and Public Opinion Polling (54191), Marketing Research and Public Opinion Polling (541910)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Diabetes (General) (HLAKADAA)

akta.pro secondary industry

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)

Keywords

• Diabetes market research
• Patient insights services
• Healthcare data services
• Syndicated research reports
• Custom qualitative research

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Data Services: Comprehensive reports providing definitive pictures of diabetes patient and provider experiences and opinions. Industry standard data across North America and Europe with tens of thousands of validated respondents tracked across dozens of drugs and devices.
2. Custom Research: Qualitative and quantitative research services delivered by seasoned professionals with deep diabetes expertise. Work includes partnering with clients on research design and leveraging proprietary access to hard-to-find respondents.
3. Syndicated Research Services: Semi-annual research services like T2 Insulin Insights, Diabetes Drug Trends (GLP-1 & SGLT2), and Digital Health Experience (DHx) providing regularly updated market intelligence.
4. AI Insights Platform: Beta platform launching early 2026 providing instant, data-driven answers for the diabetes market through AI-powered natural language queries against proprietary database.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

dQ&A provides diabetes-focused market research and insights services, delivering longitudinal Data Services (industry-standard syndicated reports tracking tens of thousands of validated patients and prescribers across nine countries), Custom Research (bespoke qualitative and quantitative studies leveraging proprietary panels), and an AI-powered Insights Platform (currently in beta) that uses natural language processing to query a 15-year proprietary data lake. The company serves pharmaceutical companies, medical device manufacturers, digital health companies, and consumer goods manufacturers with a 100% diabetes focus.

Product overview

dQ&A is a diabetes-focused market research and insights company offering a portfolio of data services, custom research, and an AI-powered insights platform. Its core Data Services provide longitudinal, representative survey data on diabetes patient and provider experiences tracked across nine countries and updated regularly. Supporting data services include T2 Insulin Insights (type 2 insulin patient experiences), Diabetes Drug GLP-1 & SGLT2 Trends (prescribing and patient behavior tracking), and DHx (Digital Health Experience, evaluating 25+ digital health apps). Custom Research offers bespoke qualitative and quantitative studies leveraging dQ&A's proprietary respondent panels. A new AI Insights Platform — currently in beta with formal launch expected early 2026 — uses natural language processing to answer diabetes business questions by querying dQ&A's proprietary data lake. The Diadem Insights Partnership with LMC Healthcare links real-world patient experience data with clinical outcomes data. Research initiatives include COVID-19 impact tracking, conference presentations at ATTD and EASD, FDA advisory testimony, and peer-reviewed publications in journals such as Clinical Diabetes and Current Diabetes Reports.

Differentiator

Problem solved

Functional benefit

Products and services

• Data Services Industry-standard syndicated data services providing comprehensive reports on diabetes patient and provider experiences and opinions across North America and Europe, tracking tens of thousands of validated respondents across dozens of drugs and devices. Subscribed to by pharmaceutical, medical device, and digital health clients for ongoing market intelligence.
• Custom Research Bespoke qualitative and quantitative research services delivered by seasoned diabetes-focused professionals, leveraging dQ&A's proprietary panel access to hard-to-reach respondents. Supports concept testing, product testing, marketing and messaging testing, patient and provider preferences, prescribing drivers, and patient reported outcomes.
• AI Insights Platform A natural-language AI-powered platform that answers diabetes-related business and research questions in seconds by querying dQ&A's proprietary 15-year data lake, generating report-ready visualizations. Currently in beta with formal launch expected early 2026; available to selected Data Services clients first.
• DHx (Digital Health Experience) A semi-annual syndicated research service studying digital health apps in diabetes, exploring patient preferences, satisfaction, outcomes, engagement, and loyalty across 25 leading apps (including Abbott FreeStyle Libre, Dexcom CLARITY, mySugr, and Glooko).
• Diabetes Drug (GLP-1 & SGLT2) Trends
• T2 Insulin Insights A semi-annual syndicated research service exploring the lived experience of people with type 2 diabetes who take insulin, based on in-depth research with thousands of patients and over a decade of trended data.
• First Look Insights A syndicated qualitative research service providing the earliest possible qualitative insights from real-world patient experiences with just-launched diabetes products, using structured and proven research techniques.
• Diadem Insights A research service created in partnership with LMC Healthcare that connects real-world patient experience data from dQ&A's panels with LMC's clinical database (50,000+ patients, 60+ data points per individual) to explore connections between daily patient behavior and clinical outcomes.

Quantifiable outcome

• 15 years of 100% diabetes focus with 400+ client projects completed
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

One partnership is on record.

• LMC HealthcarecoreStrategic or Co-development Partner · 10 July 2023Diadem Insights partnership combining dQ&A's patient experience insights with LMC's clinical database of 50,000+ patients. The partnership integrates real-world behavioral and attitudinal data with clinical outcomes including prescriptions, health markers, and demographics to deliver holistic understanding of diabetes care challenges and opportunities for improvement.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Global leader in clinical research, real-world evidence, and healthcare market research, including diabetes therapeutic insights. Competes with dQ&A for enterprise pharma and device manufacturer insight dollars; while much larger, addresses the same buying centers for syndicated and custom diabetes research.
• Kantar Health: Established healthcare market research and insights division within Kantar, covering multiple therapeutic areas. Competes with dQ&A on patient experience research, brand tracking, and syndicated insights for pharma and medical device clients.
• Trinity Life Sciences: Life sciences strategy and insights consultancy providing primary market research, real-world evidence, and patient insights to pharma and biotech. Functional overlap with dQ&A's custom qualitative/quantitative research work for life sciences clients, with a broader therapeutic footprint.
• ZS Associates: Global consulting and market research firm with significant pharma commercial and real-world evidence practices, including diabetes category work. Competes with dQ&A for patient-level insights, patient journey, and commercial strategy engagements with pharma and med-device manufacturers.
• DRG / Clarivate: Large-scale healthcare market intelligence, real-world evidence, and syndicated research provider across many therapeutic areas including diabetes. Comparable data-product and pharma-subscription business model to dQ&A's, though much broader portfolio and orders of magnitude larger.

Emerging players

• Toluna: Global digital consumer and healthcare insights panel provider, offering survey-based research and syndicated data products. Comparable technology stack and panel-driven model to dQ&A's, with broader therapeutic and consumer coverage.
• PMCB (now Within3): Healthcare-focused market research and insights platform for oncology and other specialty therapeutic areas. Comparable in scale and depth of vertical specialization, addressing similar enterprise client needs for primary market research and advisory services.

Direct peers

• Spherix Global Insights: Specialty healthcare market research firm focused on patient and provider insights in niche therapeutic categories (immunology, nephrology, GI, oncology). Closest functional comp to dQ&A: similar size, similar bespoke + syndicated model, similar enterprise pharma/med-device clients.
• Schlesinger Group: Global market research data and qualitative services company operating proprietary panels and recruitment for consumer and healthcare research. Comparable to dQ&A in panel-based qualitative/quantitative design and enterprise healthcare client base.
• InCrowd (Apollo Intelligence): On-demand market research for healthcare and life sciences, leveraging proprietary respondent panels of physicians and patients. Comparable to dQ&A's panel-based model and customer base of pharma, biotech, and device companies seeking rapid qualitative and quantitative insights.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/dqaresearch
• Facebookfacebook.com/dQandA
• LinkedInlinkedin.com/company/d-qa

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about dQ&A